Related Experiment Video

Updated: Feb 17, 2026

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
05:51

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

4.5K

A new scale for the assessment of pain in Parkinson's disease

Anette Schrag1

  • 1Department of Clinical Neurosciences, UCL Institute of Neurology, London, United Kingdom.

Movement Disorders : Official Journal of the Movement Disorder Society
|August 1, 2015
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
10:41

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia

Published on: September 12, 2020

8.0K
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

16.4K

Related Experiment Videos

Last Updated: Feb 17, 2026

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
05:51

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

4.5K
Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
10:41

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia

Published on: September 12, 2020

8.0K
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

16.4K

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

2.1K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.1K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.2K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K

Articles linked to this work by shared authors, journal, and citation graph.

Comparison of automated white matter lesion segmentation approaches for use in large, multi-site data analyses in Parkinson's disease.

Frontiers in neuroscience·2026

Measuring what matters: Evaluating quality of life instruments through the eyes of people with Parkinson's disease.

Journal of Parkinson's disease·2026

Ursodeoxycholic Acid and Parkinson's Disease Risk: An Emulated Target Trial in UK Electronic Health Records.

Movement disorders : official journal of the Movement Disorder Society·2026

Apathy in Lewy Body Disorders: A Position Paper.

Movement disorders : official journal of the Movement Disorder Society·2026

Clinical Validity of Wrist- and Trunk-Worn Sensor-Derived Data Models in Parkinson's Disease.

Parkinson's disease·2026

Non-pharmacological and non-surgical therapies in advanced Parkinson's disease: a narrative review and call to action.

Journal of neural transmission (Vienna, Austria : 1996)·2026

SLC20A2 Intragenic Structural Variants as a Cause of Primary Brain Calcification.

Movement disorders : official journal of the Movement Disorder Society·2026

Remote Versus In-Person Follow-up Programming After Subthalamic Deep Brain Stimulation for Parkinson's Disease: A Multicenter Randomized Noninferiority Trial.

Movement disorders : official journal of the Movement Disorder Society·2026

Latent Class Trajectory Modeling Identifies Cerebrospinal Fluid Protein Signatures Associated with Motor Progression in Parkinson's Disease: Evidence from the Parkinson's Progression Markers Initiative Cohort.

Movement disorders : official journal of the Movement Disorder Society·2026

Cross-Cohort Evidence Links KCNJ6 rs702859 to Impulsive-Compulsive Phenotypes in Parkinson's Disease.

Movement disorders : official journal of the Movement Disorder Society·2026

Determinants of Cueing Responsiveness in Parkinson's Disease: Insights from the UNITE-PD Study.

Movement disorders : official journal of the Movement Disorder Society·2026

Cortical Cholinergic Pathway Degeneration Reflects Cognitive Impairment and Dementia in Parkinson's Disease.

Movement disorders : official journal of the Movement Disorder Society·2026

Polysomnographic and nocturnal heart rate correlates of cognitive impairment in Parkinson's disease: a cross-sectional study.

Frontiers in neurology·2026

Nonpharmacological Interventions in Degenerative Cerebellar Ataxia: A Systematic Review.

Movement disorders clinical practice·2026

Functional Connectivity and White Matter Microstructural Alterations of Thalamic Subregions in Benign Paroxysmal Positional Vertigo.

Brain research bulletin·2026

Nailfold capillary alterations in pediatric asthma: evidence of peripheral microvascular involvement.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026

Unusual Isolated Thymic Relapse of Neuroblastoma Detected By 123I-mIBG Scintigraphy in a Pediatric Patient.

Clinical nuclear medicine·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us